cephalosporin c has been researched along with Infections, Klebsiella in 358 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 64 (17.88) | 18.7374 |
1990's | 63 (17.60) | 18.2507 |
2000's | 93 (25.98) | 29.6817 |
2010's | 106 (29.61) | 24.3611 |
2020's | 32 (8.94) | 2.80 |
Authors | Studies |
---|---|
Bianco, G; Boattini, M; Bondi, A; Cavallo, R; Comini, S; Costa, C; Iannaccone, M | 1 |
Doi, Y; Fowler, EL; Iovleva, A; McElheny, CL; Shields, RK | 1 |
Gasser, M; Harbarth, S; Kronenberg, A; Plüss-Suard, C; Renggli, L | 1 |
Busquets, A; Ferreira, C; Fialho, AM; Gomila, M; Henriques, I; Manaia, CM; Mil-Homens, D; Rocha, J | 1 |
Standing, JF | 1 |
Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
Darlow, CA; Hope, W | 1 |
Cremanns, M; Gatermann, SG; Lange, F; Pfennigwerth, N | 1 |
Burd, EM; Davis, MH; Jacob, JT; Ozturk, T; Satola, SW; Steed, DB; Weiss, DS; Witt, LS | 1 |
Chen, IR; Chen, L; Chou, SH; Juan, CH; Lin, YT; Yang, CI | 1 |
Huang, E; Jun, SR; Moon, SH; Udaondo, Z | 1 |
Karas, JA; Longshaw, CM; Santerre Henriksen, A; Slover, C; Yamano, Y | 1 |
Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
Findlay, J; Nordmann, P; Poirel, L; Rens, C | 1 |
Burd, EM; Jacob, JT; Ozturk, T; Satola, SW; Weiss, DS; Witt, LS | 1 |
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z | 1 |
Huang, E; Moon, SH | 1 |
Han, X; Hu, H; Jiang, Y; Liao, W; Meng, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhao, D; Zhou, J | 1 |
Aghdassi, SJS; Behnke, M; Denkel, LA; Diaz, LAP; Gastmeier, P; Häussler, S; Kola, A; Maechler, F; Neffe, L; Thoma, N; Weber, A | 1 |
Ambretti, S; Gaibani, P; Lazzarotto, T; Viale, P | 1 |
Cuesta, M; Gonzalez-Zorn, B; Hoefer, A; Ortega-Huedo, R | 1 |
Ahmad Kamar, A; Chong, CW; Ngoi, ST; Teh, CSJ; Yap, PSX | 1 |
Granier, SA; Mesbah Zekar, F; Millemann, Y; Touati, A | 1 |
Fuenzalida, MJ; Ruegg, PL | 3 |
Goudarzi, G; Shakib, P | 1 |
Heuer, O; Högberg, LD; Monnet, DL; Peñalva, G; Vlahović-Palčevski, V; Weist, K | 1 |
Karlowsky, JA; Kazmierczak, KM; Motyl, MR; Sahm, DF; Young, K | 1 |
Shields, RK | 1 |
Amore, D; Anile, M; Bassi, M; Cagnetti, S; Carillo, C; D'Agostino, FG; De Giacomo, T; Diso, D; Mantovani, S; Mottola, E; Pagini, A; Pecoraro, Y; Poggi, C; Pugliese, F; Rendina, EA; Russo, G; Vannucci, J; Venuta, F | 1 |
Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P | 1 |
Dong, H; Hu, X; Stålsby Lundborg, C; Sun, X; Zhen, X | 1 |
Albert, E; Colomina, J; Costa, RM; Giménez, E; Huntley, D; Navarro, D; Olea, B; Oltra, R; Pascual, T; Pinto, C; Sánchez, D; Torres, I; Valdivia, A | 1 |
Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R | 1 |
Ajilda, AAK; Padmini, N; Selvakumar, G; Sivakumar, N | 1 |
Echols, R; Hoover, J; Matsumoto, S; Nakamura, R; Rittenhouse, S; Singley, CM; Tsuji, M; Yamano, Y | 1 |
Cerdeira, L; Cunha, MPV; Davies, YM; Dropa, M; Knöbl, T; Lincopan, N | 1 |
Chen, CC; Chuang, YC; Ku, YH; Lee, MF; Tang, HJ; Yang, YC; Yu, WL | 1 |
Bialek-Davenet, S; Brisse, S; Duprilot, M; Mayer, N; Nicolas-Chanoine, MH; Pagès, JM; Vergalli, J | 1 |
Dahdouh, E; Daoud, Z; Doron, S; Irani, J; Matar, GM; Salem-Sokhn, E | 1 |
Deng, J; Li, SL; Li, YT; Lin, HL; Niu, JJ; Shen, X; Yang, TC; Yu, YW; Zhao, QF | 1 |
Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
Abodakpi, H; Cantón, R; Chan, K; Chang, KT; Lasco, TM; Sánchez Díaz, AM; Sofjan, AK; Tam, VH | 1 |
Bansal, N; Gopalakrishnan, R; Kumar D, S; Nambi, PS; Ramasubramanian, V; Sukhwani, KS | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Boerlin, P; Chalmers, G; Dick, H; Reid-Smith, RJ; Shen, X; Slavic, D; Zhang, PLC | 1 |
Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ | 1 |
Beovic, B; Kreft, S; Mueller Premru, M; Nadrah, K; Pirs, M | 1 |
Araújo, BF; Batistão, DWDF; Campos, PA; Cerdeira, LT; de Brito, CS; Ferreira, ML; Gonçalves, IR; Gontijo-Filho, PP; Ribas, RM; Royer, S | 1 |
Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
Caro, L; Huntington, JA; Long, J; Xiao, AJ | 1 |
Dai, C; Hao, Z; Li, Y; Qu, S; Zhao, L; Zhu, J | 1 |
Dai, E; Duan, X; Fang, H; Feng, J; Gao, B; Luo, Y; Tong, Y; Wang, J; Xu, Y; Yin, Z; Zhan, Z; Zhang, Y; Zhou, D | 1 |
Deng, Z; Li, G; Li, X; Liang, W; Liu, J; Ou, HY; Qu, H; Sun, J; Tian, L; Wang, X; Xie, Y | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Antona, C; Bandi, C; Brilli, M; Comandatore, F; Dichirico, B; Gismondo, MR; Piazza, A; Ridolfo, A; Rimoldi, SG; Romeri, F | 1 |
Abdelaziz, A; El-Ekhnawy, E; Elbanna, T; Sonbol, F | 1 |
Castellanos, Á; Frasquet, J; Gordon, M; Martín, M; Ramirez, P; Ruiz, J; Sánchez, MÁ; Villarreal, E | 1 |
Almirante, B; Escolà-Vergé, L; González-López, JJ; Larrosa, N; Len, O; Los-Arcos, I; Pigrau, C; Viñado, B | 1 |
Crook, DW; Davies, T; Day, NPJ; Giess, A; Mao, S; Moore, CE; Parry, CM; Peto, TEA; Phot, N; Sheppard, AE; Stoesser, N; Suy, K; Turner, P; van Aartsen, JJ; Walker, AS | 1 |
Dai, C; Hao, Z; Huang, T; Qu, S; Tang, Q; Wang, H; Yang, F; Zhang, Y | 1 |
Biamonte, E; Bruni, A; Garofalo, E; Liberto, MC; Lionello, R; Longhini, F; Marascio, N; Matera, G; Mazzitelli, M; Navalesi, P; Quirino, A; Scaglione, V; Serapide, F; Torti, C; Trecarichi, EM | 1 |
Bettiol, M; Corso, A; De Belder, D; Faccone, D; Gatti, B; Gomez, S; Pasteran, F; Petroni, A; Rapoport, M; Veliz, O | 1 |
Berrazeg, M; Drissi, M; Medjahed, L; Rolain, JM | 1 |
Bell, SM; Ginn, AN; Gottlieb, T; Harkness, J; Iredell, JR; Leroi, MJ; Macleod, C; Merlino, J; Partridge, SR; Thomas, LC; van Hal, S; Wiklendt, AM; Zong, Z | 1 |
Endimiani, A; Hilty, M; Kronenberg, A; Muhlemann, K | 1 |
Edquist, P; Melhus, Å; Starlander, G; Yin, H | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Stucki, A | 1 |
Ambrose, PG; Bhavnani, SM; Bulik, CC; Forrest, A; Friedrich, LV; Jones, RN; McCauley, J; Mendes, RE; Okusanya, OO; Steenbergen, JN; Vanscoy, B | 1 |
Bai, C; Chen, Y; Li, D; Zhang, P; Zhang, Q; Zhang, W; Zheng, S | 1 |
Bousquet-Mélou, A; Ferran, AA; Henri, J; Laurentie, M; Perrin-Guyomard, A; Rolland, JG; Toutain, PL; Vasseur, MV | 1 |
Nobari, S; Rahmati Ghezelgeh, F; Shahcheraghi, F; Valizadeh, B | 1 |
Condon, S; Ginocchio, CC; McWilliams, CS; Schwartz, RM | 1 |
Boutin, MA; Harris, AD; Hazen, TH; Johnson, JK; Rasko, DA; Robinson, G; Stancil, A; Zhao, L | 1 |
Axelrod, P; Gallagher, JC; Haynes, K; Kuriakose, S | 1 |
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G | 1 |
Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Jung, SW; Kang, JH; Kim, HK; Lee, DG; Lee, JW; Park, YJ | 1 |
Achkar, M; Charrouf, FO; Dabboussia, F; Hamze, M; Mallat, H | 1 |
Bassetti, M; Righi, E | 1 |
Choi, JY; Chong, Y; Chung, HS; Kim, JM; Ku, NS; Lee, K; Yong, D | 1 |
Alkatib, S; Chalana, IK; Chaudhry, K; Chopra, T; Johnson, PC; Kaye, KS; Marchaim, D; Mohammed, M; Pogue, JM; Tamam, Z; Tansek, R; Zhao, JJ | 1 |
Chow, DC; Fryszczyn, B; Hu, L; Nordmann, P; Palzkill, T; Poirel, L; Prasad, BV; Sankaran, B; Stojanoski, V | 1 |
Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O | 1 |
Gentry, CA; Williams, RJ | 1 |
Du, X; Fu, Y; Ji, S; Jiang, Y; Lv, F; Mu, X; Wei, Z; Yu, Y | 1 |
Baraniak, A; Bonten, MJ; Brisse, S; Brun-Buisson, C; Carmeli, Y; Derde, LP; Fiett, J; Gniadkowski, M; Goossens, H; Hryniewicz, W; Izdebski, R; Urbanowicz, P | 1 |
Kluytmans, JA; Leenstra, T; van der Bij, AK; van der Steen, M | 1 |
Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
Chang, EK; Huang, YT; Kao, KL; Liao, CH; Liu, CY; Tsai, MS; Yang, CJ | 1 |
Jalava, J; Kärki, T; Lyytikäinen, O; Martelius, T; Möttönen, T; Ollgren, J | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Jiang, Y; Kuang, L; Li, L; Li, M; Wang, H; Zhou, W | 1 |
Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S | 1 |
Bastos, MS; Cardoso, CL; Garcia, LB; Menegucci, TC; Moreira, RRB; Tognim, MCB; Viana, GF | 1 |
Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C | 1 |
Biedenbach, DJ; Bouchillon, SK; de Jonge, BL; Hackel, M; Hoban, DJ; Kazmierczak, KM; Stone, GG | 1 |
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
Arlet, G; Boyd, A; Decré, D; Girard, PM; Surgers, L | 1 |
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O | 1 |
Bamford, C; Buys, H; Eley, B; Muloiwa, R | 1 |
Akagi, M; Kida, K; Kofuku, T; Komatsu, M; Mizutani, T; Nakai, I; Nakamura, T; Nishi, I; Nishio, H; Ono, T; Orita, T; Satoh, K; Sueyoshi, N; Toda, H; Wada, Y; Yamasaki, K; Zikimoto, T | 1 |
Chang, FY; Chang, SC; Chen, YS; Chuang, YC; Fung, CP; Huang, IW; Lai, JF; Lauderdale, TL; Lin, WP; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Lee, NY | 1 |
Chen, CE; Shih, YC | 1 |
Diaz-Martinez, LA; Ramirez-Blanco, CE; Ramirez-Rivero, CE; Sosa-Avila, LM | 1 |
Anupurba, S; Banerjee, T; Basu, S; Bhattacharjee, A; Kumar, A; Mishra, S; Sen, MR; Tiwari, K; Upadhyay, S | 1 |
Adler, AL; Burnham, CA; Das, S; Elward, A; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Selvarangan, R; Sullivan, KV; Weissman, SJ; Zaoutis, T; Zerr, DM | 1 |
Chen, YS; Huang, CK; Lee, SS; Lin, HH; Liu, YC; Tsai, HC; Wann, SR | 1 |
Harbarth, S; Huttner, B; Pittet, D | 1 |
Akalin, H; Gürcüoglu, E; Helvaci, S; Heper, Y; Kordan, Y; Mistik, R; Ozakin, C; Ozbey, S; Sinirtaş, M; Yilmaz, E | 1 |
Bechtold, A; Gastmeier, P; Lapatschek, M; Meyer, E; Schwab, F; Schwarzkopf, G | 1 |
Chen, YH; Liu, ZY; Wu, R; Yao, WZ; Zhang, XW; Zhou, QT | 1 |
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Agarwal, SK; Bhowmik, DM; Gupta, A; Lal, C; Mahajan, S | 1 |
Chaudhary, M; Dwivedi, VK; Shrivastava, SM; Singh, CP; Soni, A | 1 |
Cao, W; Gao, Y; Wu, Y; Yang, Y; Zhou, Q | 1 |
Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H | 1 |
Hu, F; Wu, W; Xu, X; Ye, X; Zhu, D | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR | 1 |
Correia, JB; Gusmão-Filho, FA; Levy, SS; Mello, MJ | 1 |
Cha, TL; Chang, HC; Huang, PW; Tang, SH | 1 |
Chopra, T; Fairfax, MR; Kaye, KS; Pogue, JM; Saely, S | 1 |
Chang, FY; Chen, JH; Chen, TL; Fung, CP; Lin, JC; Siu, LK; Tsai, YK | 1 |
Cars, O; Eriksson, BM; Melhus, A; Svennblad, B; Tängdén, T | 1 |
Ge, Y; Giske, CG; Karlsson, IM; Titelman, E | 1 |
Leung, CH; Liu, CK; Liu, CP; Sun, FJ | 1 |
Choi, SC; Lee, JY; Seo, GS | 1 |
Chandrasekhar, MR; Krishna, BV; Patil, A | 1 |
Brown, D; Castanheira, M; Critchley, I; Drusano, GL; Grasso, C; Jones, RN; Kulawy, R; Liu, W; Louie, A; Thye, D; Vanscoy, B; Williams, G | 1 |
Bulik, CC; Keel, RA; Nicolau, DP; Sutherland, CA; Tessier, PR | 1 |
Belomestnykh, N; Bennett, GJ; Ceglowski, B; Rauch, BJ; Saltman, RL; Schukken, YH; Sharkey, HL; Thomas, MJ; Zadoks, RN; Zurakowski, MJ | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A | 1 |
Ghafourian, S; Khosravi, A; Neela, V; Rahbar, M; Sadeghifard, N; Sekawi, Z | 1 |
Boisier, P; Breurec, S; Brisse, S; Cao, V; Dufougeray, A; Garin, B; Guessennd, N; Kinana, A; Le, TA; Ngandjio, A; Perrier-Gros-Claude, JD; Randrianirina, F; Thiberge, JM; Timinouni, M | 1 |
Mondal, A; Rajamohan, G; Srinivasan, VB; Vaidyanathan, V | 1 |
Abdelaziz, MO; Aleo, A; Bonura, C; El-Domany, RA; Fasciana, T; Mammina, C | 1 |
Kariuki, S; Maina, D; Ozwara, H; Revathi, G | 1 |
Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
Aasnæs, B; Dahl, KH; Naseer, U; Sundsfjord, A; Tofteland, S | 1 |
Eller, C; Pfeifer, Y | 1 |
Kim, BN; Kim, YS; Ryu, J; Woo, JH | 1 |
McGeer, A; Muller, M | 1 |
Bartlett, PC; Erskine, RJ; Phipps, CR; VanLente, JL | 1 |
Blahová, J; Jezek, P; Králiková, K; Krćméry, V; Vaculíková, A | 1 |
Nakahama, C | 1 |
Chang, FY; Cheng, HP; Siu, LK | 1 |
Gedikoglu, S; Kazak, E; Ozakin, C; Sevgican, E; Sinirtaş, M | 1 |
Arango, C; Bantar, C; Coassolo, MA; Duret, F; Fiorillo, A; Franco, D; Gomez, H; Heft, C; Krayeski, M; Oliva, ME; Salamone, F; Vesco, E | 1 |
Choi, MK; Fish, DN; Husain, M; Jung, R | 1 |
Laufs, R; Mack, D; Noor, D; Sobottka, I; Stürenburg, E | 1 |
Arakawa, Y; Doi, Y; Ito, H; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K | 1 |
Draghi, DC; Jones, ME; Karlowsky, JA; Nathwani, D; Sahm, DF; Thornsberry, C | 1 |
Bae, IK; Jeong, BC; Jeong, SH; Jung, HI; Kim, SJ; Kwon, SB; Lee, JH; Lee, SH; Song, JS | 1 |
Chen, YS; Kao, CH; Lee, SS; Liu, YC; Tsai, HC; Wann, SR | 1 |
Amyes, SG; Bello, H; Dominguez, M; González, G; Mella, S; Valenzuela, L; Zemelman, C; Zemelman, R | 1 |
Beceiro, A; Bou, G; Cartelle, M; del Mar Tomas, M; Dominguez, MA; Molina, F; Pertega, S; Velasco, D; Villanueva, R | 1 |
Desimoni, MC; Esquivel, GP; Merino, LA | 1 |
Cho, YK; Kim, SY; Lee, ES; Lee, SO; Park, SY; Seo, YH | 1 |
Chuang, CL; Ko, WC; Tsai, SH; Wu, HM; Wu, JJ; Yan, JJ | 1 |
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C | 1 |
Chia, JH; Lee, CH; Liu, JW; Su, LH; Tsai, KT; Wu, TL | 1 |
Bell, LM; Bilker, WB; Chu, JH; Coffin, SE; Goyal, M; Lautenbach, E; McGowan, KL; Nachamkin, I; Zaoutis, TE | 1 |
Chiarini, F; Conte, MP; D'Ettorre, G; Gallinelli, C; Orsi, GB; Scoarughi, GL; Venditti, M; Zamboni, I | 1 |
Barone, AA; Boszczowski, I; Costa, SF; Levin, AS; Nicoletti, C; Pinheiro, M; Puccini, DM; Soares, RE; Van der Heijden, IM | 1 |
Hawkey, PM; Livermore, DM | 1 |
Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM | 1 |
Hanson, ND; Jorgensen, JH; Lewis, JS; Moland, ES; Song, W; Thomson, KS | 1 |
Kotapati, S; Kuti, JL; Nicolau, DP; Nightingale, CH | 1 |
Arisoy, AE; Arisoy, ES; Gundes, S; Karaali, E; Kolayli, F; Sanic, A; Turker, G; Vahaboglu, H | 1 |
Bochnia, M; Dziewiszek, W; Orendorz-Fraczkowska, K; Smutnicka, D; Stankiewicz, M | 1 |
Cal, RG; Castelo, A; do Carmo Filho, JR; Marra, AR; Pereira, CA; Sader, HS; Wey, SB | 1 |
Ambrose, PG; Ramphal, R | 1 |
Chang, FY; Chen, HM; Chuang, YC; Hsueh, PR; Lin, TP; Liu, YC; Lu, JJ; Shyr, JM; Tsao, SM; Wan, JH; Wang, LS; Wu, HH; Wu, HM; Wu, JJ; Yan, JJ; Yang, YC | 1 |
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL | 1 |
Paterson, DL | 1 |
Duttaroy, B; Mehta, S | 1 |
Caniça, M; Ferreira, E; Mendonça, N | 1 |
Bulitta, J; Kirkpatrick, CM; Lipman, J; Roos, JF | 1 |
Golia, P; Sadler, M | 1 |
Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
Bang, JW; Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, NJ; Kim, SH; Oh, MD | 1 |
Liu, YN; She, DY; Wang, WF | 1 |
Kuti, JL; Lee, SY; Nicolau, DP | 1 |
Ensor, VM; Evans, JT; Hawkey, PM; Shahid, M | 1 |
Choi, TY; Pai, H; Seo, MR | 1 |
Labombardi, VJ; Rojtman, A; Tran, K | 1 |
Jeong, SH; Kim, HS; Kim, J; Kim, JS; Lee, KM; Roh, KH; Song, W | 1 |
Mahanta, J; Nath, R; Saikia, L | 1 |
Arnesi, N; Bencomo, B; Bermejo, J; Borda, N; Lesnaberes, P; Notario, R | 1 |
Fluit, AC; Gaastra, W; van Duijkeren, E; Vo, AT | 1 |
Agarwal, N; Agarwal, S; Arya, SC; Solanki, BS | 1 |
Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH | 1 |
Kolár, M; Lovecková, Y; Santavá, L; Strojil, J; Urbánek, K | 1 |
Hwang, KP; Kuo, KC; Shen, YH | 1 |
Du, M; Huang, Y; Zhuang, S | 1 |
Blot, SI; Decruyenaere, JM; Depuydt, PO; Vandijck, DM | 1 |
Bagattini, M; Crivaro, V; Raimondi, F; Rossano, F; Salza, MF; Triassi, M; Zarrilli, R | 1 |
Gustafsson, I; Hallgren, H; Ripa, T | 1 |
Adams-Haduch, JM; de Oliveira Garcia, D; Doi, Y; Freire, MP; Leite, D; Padoveze, MC; Paterson, DL; Silveira, FP; Szabo, D; Vaz, TM | 1 |
Boo, TW; Crowley, B; Roche, C; Walsh, F | 1 |
Kim, JY; Kim, MJ; Kim, YM; Park, DW; Sohn, JW; Yoon, YK | 1 |
Burdon, DW; Clarke, P; Clements, D; Eastwood, D; Keighley, MR | 1 |
Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
Dusehu, E; Lallement, PY; Philippe, JM; Veyssier, P | 1 |
Bakker-Woudenberg, IA; Michel, MF; van den Berg, JC | 1 |
Andreoni, G; Angela, GC; Bendiscioli, L; Braida, M; Bramato, C; Capra, E; Cignolo, G; di Nola, F; Eandi, M; Lollini, P; Musso, E; Pizzo, L; Salassa, B; Soranzo, ML; Spezia, C | 1 |
Abbas, AM; Cantor, AM; Haste, AR; Jones, RB; Newby, D; Rigby, CC; Taylor, MC | 1 |
Alford, RH; Brown, TH | 1 |
Bentley, DW | 1 |
Cherubin, CC; Cleri, D; Corrado, ML; Gombert, M; Landesman, SH | 1 |
McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
Ellis-Pegler, RB; Lang, SD | 1 |
Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
Angehrn, P; Arisawa, M; Glauser, MP; Then, RL | 1 |
Kasanen, A; Nikoskelainen, J; Saarimaa, H; Toivanen, P | 1 |
Ullmann, U | 1 |
Chrzanowska, I; Prusek, W; Springer, L; Zygmunt, A | 1 |
Nishi, T; Tsuchiya, K | 1 |
Preheim, LC; Sanders, WE | 1 |
Berthiaume, JT; Pien, FD | 1 |
Montgomerie, JZ; Ota, JK | 1 |
Cappelletty, DM; Kang, SL; Palmer, SM; Rybak, MJ | 1 |
Babálová, M; Blahová, J; Hupková, M; Králiková, K; Krcméry, V | 1 |
Kelly, JW; McAllister, CK; Schrank, JH | 1 |
Arstila, T; Auvinen, H; Huovinen, P | 1 |
Low, DE; Scriver, SR; Toye, BW | 1 |
Chen, ST; Tang, LM | 1 |
Arlet, G; Fournier, G; Lagrange, PH; Philippon, A; Rouveau, M | 1 |
Gwanzura, L; Kowo, H; Mason, PR; Mubaiwa, L; Nathoo, KJ | 1 |
Hayashi, R; Iizawa, Y; Imada, A; Iwahi, T; Okonogi, K; Yamazaki, T | 1 |
Bonomo, RA; Carias, LL; Rice, LB; Shlaes, DM | 1 |
Gourkou, A; Hatzoudis, G; Legakis, NJ; Pitt, TL; Tzelepi, E; Tzouvelekis, LS; Vatopoulos, AC | 1 |
Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K | 1 |
Archinal, W; Kacica, MA; Limberger, R; Preston, KE; Root, TP; Scarano, FJ; Steele, LM; Venezia, RA | 1 |
Karas, JA; Muckart, D; Pillay, DG; Sturm, AW | 1 |
Hashemi, FN; Hayden, MK; Matushek, MG; Miyashiro, D; Quinn, JP; Schiappa, DA; Smith, KY; Sullivan, J; Trenholme, GM; Weinstein, RA | 1 |
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
DeVente, J; Eckstein, EC; Rice, LB; Shlaes, DM | 1 |
Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M | 1 |
Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
Arakawa, Y; Ito, H; Kato, N; Kimura, K; Kurokawa, H; Ohsuka, S; Ohta, M; Suzuki, K | 1 |
Livermore, DM; Yuan, M | 1 |
Daniel, M; Johnson, AP; Malde, M; Wallace, MR; Yousif, AA | 1 |
Bourlinou, PK; Karachalios, GN; Nasiopoulou, DD; Reppa, A | 1 |
Ban, Y; Deguchi, T; Fukuoka, A; Ishihara, S; Kanematsu, E; Kawada, Y; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
Crellin, J; Medeiros, AA | 1 |
Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C; Tripodi, MF | 1 |
Berry, P; Branger, C; Bruneau, B; Lambert-Zechovsky, N; Lesimple, AL | 1 |
Chang, WN; Lu, CH; Wu, HS | 1 |
Abachin, E; Arlet, G; Berche, P; Gaillot, O; Lecuru, F; Maruéjouls, C; Simonet, M | 1 |
Antony, B; Kumari, PG; Rao, PL; Shivananda, PG | 1 |
Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
Bhachech, N; Bradford, PA; Bush, K; Jett, BD; Sahm, DF; Yang, Y | 1 |
Moland, ES; Sanders, CC; Thomson, KS | 1 |
Blahová, J; Hupková, M; Králiková, K; Krcméry, V; Kubonová, K; Lísková, A | 1 |
García Sánchez, E; Hortelano López, M; Izquierdo García, A; López-Herce Cid, J; Panadero Carlavilla, E; Sánchez Sánchez, C | 1 |
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
Dohmen, K; Irie, K; Ishibashi, H; Miyamoto, Y; Onohara, S; Shimada, T; Shirahama, M | 1 |
Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Palucha, A | 1 |
Asakawa, A; Fujino, MA; Kasai, H; Kashiwagi, A; Matsumoto, Y; Ohtaka, M | 1 |
Lawrence, C; Nauciel, C; Ronco, E | 1 |
Bedenic, B; Zagar, Z | 1 |
Bradford, PA; Bush, K; Goering, RV; Nathan, C; Quinn, JP; Weinstein, RA; Wiener, J | 1 |
Ono, Y; Sugiyama, H | 1 |
Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Shah, AH | 1 |
Choe, KW; Kim, J; Kim, JW; Kwon, Y; Lee, JH; Lyu, S; Pai, H | 1 |
Bedford, H; Harvey, D; Holt, DE | 1 |
Katsanis, G; Tzelepi, E; Tzouvelekis, LS; Vatopoulos, AC | 1 |
Bergeron, MG; Bergeron, Y; Deslauriers, AM; Gauthier, MC; Ouellet, N | 1 |
Aliaga Martínez, L; Arrebola Nacle, JP; Cobo Martínez, F; de la Rosa Fraile, M; Díaz Monllor, F; Mediavilla García, JD | 1 |
Corso, A; Galas, M; Rossi, A; Soloaga, R; Tokumoto, M | 1 |
Abdullah, WA; Arasu, A; Ariffin, H; Lee, CL; Mohamed, M; Navaratnam, P; Peng, LH | 1 |
Barroso, H; Cristino, JM; Duarte, A; Freitas-Vieira, A; Lito, LM; Moura, T; Neto, HF; Salgado, MJ; Sousa, JC; Soveral, G | 1 |
Arlet, G; Donay, L; Herrmann, J; Lagrange, PH; Nadjar, D; Philippon, A; Rouveau, M; Verdet, C | 1 |
Dimopoulou, H; Miriagou, V; Platsouka, E; Tzelepi, E; Tzouvelekis, LS | 1 |
Moller, JK; Scheibel, J; Schumacher, H | 1 |
Egorova, OA; Golovaneva, NB; Khantemirov, RG; Konovalov, AV; Shul'man, FI | 1 |
Carter, MW; Livermore, DM; Oakton, KJ; Warner, M | 1 |
Crichton, M; Gibb, AP | 1 |
Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D | 1 |
Bush, K; Mariano, N; Montenegro, D; Queenan, AM; Rahal, JJ; Rahman, N; Urban, C | 1 |
Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
Noy, A; Orni-Wasserlauf, R; Siegman-Igra, Y; Sorkine, P | 1 |
Bonomo, RA; Casellas, JM; Klugman, KP; Ko, WC; McCormack, JG; Mulazimoglu, L; Paterson, DL; Rice, LB; Von Gottberg, A; Yu, VL | 1 |
Chi, CL; Yeh, LL | 1 |
Luo, G; Luo, H; Tan, X | 1 |
Bedenić, B; Hächler, H; Randegger, CC; Stobberingh, E | 1 |
Ang, LP; Au Eong, KG; Lee, HM; Lim, AT; Yap, EY | 1 |
Bush, K; Hindler, J; Lee, N; Loeloff, M; Pegues, DA; Queenan, AM; Quinn, JP; Wong-Beringer, A | 1 |
Bearden, DT; Einhorn, AE; Neuhauser, MM; Pendland, SL; Quinn, JP | 1 |
Bedenić, B | 1 |
Lucas, J; Simango, C | 1 |
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB | 1 |
Ericsson, C; Marcolini, J; Nguyen, M | 1 |
Hirata, Y; Kato, M; Matsuzaki, M; Nakumura, K; Tado, N | 1 |
Chambers, S; Down, G; Dulake, C; Mortimer, PR; Noble, CJ; Palfreyman, J | 1 |
Hoyme, U; Madsen, PO | 1 |
Gentry, LO | 1 |
Fernandez, CA; Mercado, FF; Santella, PJ | 1 |
Naumann, P; Rosin, H | 2 |
Hopefl, AW | 1 |
Akita, H; Hara, N; Hotta, M; Ichihashi, Y; Izeki, M; Morikawa, Y; Nanri, S; Osano, M; Sunakawa, K; Yamashita, N | 1 |
Bint, AJ; Bullock, DW; Speller, DC; Stern, SR; Turner, A | 1 |
Hitzenberger, G | 1 |
Melo, JC; Raff, MJ; Wunderlich, HF | 1 |
Heymès, R; Lutz, A; Schrinner, E | 1 |
Benner, EJ; Bush, WG; Kranhold, JF | 1 |
Adam, D | 1 |
Berges, DA | 1 |
Brogard, JM; Lavillaureix, J; Ledoux, F; Pinget, M | 1 |
Imai, K; Kamiya, T; Koie, K; Ono, R; Yoshikawa, H | 1 |
Sato, K; Yoshino, T | 1 |
Hata, K; Nishino, T; Otsuki, M | 1 |
Ben Yaghlane-Bouslama, H; Boujnah, A; Kallel, H; Labia, R; Petit, A; Sirot, J; Sofer, L | 1 |
Goto, S; Kamimura, T; Matsumoto, S; Tawara, S | 1 |
Abe, S | 1 |
Jacoby, GA; Medeiros, AA; Papanicolaou, GA | 1 |
Lionell, C; Magni, L | 1 |
Jiang, XF | 1 |
Brus-Weijer, L; Krul, AM; Mattie, H; van Dokkum, AM; van Strijen, E | 1 |
Inouye, S; Iwamatsu, K; Katano, K; Kondo, S; Nakabayashi, S; Ogino, H; Tsuruoka, T; Yoshida, T | 1 |
Hishikawa, T; Kusunoki, T; Matsumoto, K; Nagatake, T; Sakamoto, T; Tsuchiya, K; Uzuka, Y | 1 |
Arai, S; Hayashi, S; Kobayashi, S | 1 |
Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
Inoue, M; Mitsuhashi, S; Utsui, Y | 1 |
Isert, D; Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
Phillips, L; Pitkin, DH; Uri, JV | 1 |
Bryskier, A; Chantot, JF | 1 |
Schwab, W | 1 |
Boxerbaum, B | 1 |
Micetich, RG; Raap, R | 1 |
Henning, C; Kallings, LO; Lidman, K; Sterner, G | 1 |
Dunn, GL; Guarini, JR; Hoover, JR; Jakas, DR; Lam, LL; Phillips, L; Taggart, JJ | 1 |
Steinitz, H | 1 |
Haschek, H; Porpaczy, P; Schmidt, W | 1 |
Bennett, AH; Morse, FP | 1 |
Fujisawa, K; Kawaguchi, H; Naito, T; Nakagawa, S; Takahashi, K | 1 |
Beck, D; Siegenthaler, W | 1 |
Dunmore, RT | 1 |
Bieder, L | 1 |
Kawamura, J | 1 |
Guttmann, D | 1 |
Schwarz, H; Wise, HA | 1 |
Lüthy, R; Siegenthaler, G; Siegenthaler, W; Vetter, H | 1 |
Smith, ER | 1 |
Fekety, FR; Geddes, AM; Ohkoshi, M; Turck, M | 1 |
Laxminarayana, MS; Metzger, WA; Rosenthal, IM | 1 |
13 review(s) available for cephalosporin c and Infections, Klebsiella
Article | Year |
---|---|
Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Monomicrobial Klebsiella pneumoniae Necrotizing Fasciitis With Liver Abscess: A Case Report and Literature Review.
Topics: Aged; Cephalosporins; Combined Modality Therapy; Drainage; Fasciitis, Necrotizing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male | 2017 |
[Klebsiella infection].
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillinase; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2003 |
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Treatment Outcome | 2006 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment.
Topics: Aged; Ampicillin; Bacterial Infections; Cephalosporins; Cross Infection; Haemophilus Infections; Humans; Klebsiella Infections; Leukocyte Count; Male; Mucus; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Sputum; Staphylococcal Infections | 1984 |
[Klebsiella pneumoniae pneumonia].
Topics: beta-Lactamases; Cephalosporins; Diagnosis, Differential; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin Resistance; Pneumonia, Bacterial | 1999 |
Bacterial meningitis in the newborn: a prospective study of mortality and morbidity.
Topics: Cephalosporins; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Morbidity; Prospective Studies; Streptococcal Infections; Streptococcus agalactiae | 1999 |
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Cephalosporins; Child; Female; Genotype; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2001 |
Endogenous Klebsiella endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Endophthalmitis; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome; Vancomycin; Visual Acuity | 2000 |
Empiric therapy of febrile granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 1979 |
[Sulfonamide and antibiotic usage in otolaryngology (author's transl)].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Erythromycin; Escherichia coli Infections; Gentamicins; Humans; Infant; Klebsiella Infections; Microbial Sensitivity Tests; Neomycin; Otorhinolaryngologic Diseases; Penicillins; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcal Infections; Streptomycin; Sulfonamides; Tetracycline; Tracheoesophageal Fistula | 1974 |
[Clinical picture and antibiotic therapy of bacterial septicemias in internal medicine].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Endocarditis, Bacterial; Enterobacter; Escherichia coli Infections; Germany, West; Humans; Klebsiella Infections; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1971 |
16 trial(s) available for cephalosporin c and Infections, Klebsiella
Article | Year |
---|---|
Short communication: Longitudinal study of quarter-level somatic cell responses after naturally occurring, nonsevere clinical mastitis diagnosed as culture negative, or caused by Escherichia coli or Klebsiella pneumoniae, and randomly assigned to a no-tre
Topics: Animals; Anti-Bacterial Agents; Cattle; Cell Count; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Mammary Glands, Animal; Mastitis, Bovine; Milk | 2019 |
Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Dairying; Escherichia coli; Escherichia coli Infections; Farms; Female; Klebsiella Infections; Klebsiella pneumoniae; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Milk; Random Allocation | 2019 |
Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Tigecycline | 2015 |
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult | 2017 |
Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Klebsiella Infections; Mammary Glands, Animal; Mastitis, Bovine | 2011 |
Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Clindamycin; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Klebsiella; Klebsiella Infections; Mastitis, Bovine; Milk | 2002 |
Extended-spectrum cephalosporin compared to cefazolin for treatment of Klebsiella pneumoniae-caused liver abscess.
Topics: Adult; Anti-Bacterial Agents; APACHE; Cefazolin; Cephalosporins; Drainage; Female; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Middle Aged; Risk Factors; Treatment Outcome | 2003 |
Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Respiratory System; Risk Factors | 2004 |
Measurement of gastric juice pH should not be used for selecting high risk patients requiring antibiotic prophylaxis in gastric surgery.
Topics: Cefuroxime; Cephalosporins; Female; Gastric Juice; Humans; Hydrogen-Ion Concentration; Klebsiella Infections; Male; Penicillins; Premedication; Preoperative Care; Prospective Studies; Random Allocation; Risk; Staphylococcal Infections; Stomach Diseases; Surgical Wound Infection; Ticarcillin | 1982 |
[Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cefotetan; Cephalosporins; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Enterobacteriaceae Infections; Female; Half-Life; Humans; Klebsiella Infections; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1983 |
Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.
Topics: Aged; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Drug Eruptions; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Safety | 1995 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ofloxacin; Phlebitis | 1996 |
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
Topics: Aged; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Male; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1978 |
Cefuroxime therapy for urinary tract infections caused by a multi-resistant, epidemic Klebsiella aerogenes.
Topics: Adolescent; Adult; Aged; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1979 |
[Results of clinical trials with cephadrine in children].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Cyclohexanes; Diarrhea; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Haemophilus Infections; Hematoma; Humans; Infant; Klebsiella Infections; Leukocytosis; Nausea; Osteomyelitis; Otitis; Pharyngitis; Pneumococcal Infections; Pneumonia; Proteus Infections; Pyelonephritis; Pyoderma; Sepsis; Sinusitis; Staphylococcal Infections; Streptococcal Infections; Time Factors; Vomiting | 1973 |
329 other study(ies) available for cephalosporin c and Infections, Klebsiella
Article | Year |
---|---|
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Cation Transport Proteins; Cefiderocol; Cephalosporins; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Frameshift Mutation; High-Throughput Nucleotide Sequencing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Siderophores | 2021 |
Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Hospitals; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Switzerland | 2022 |
Third generation cephalosporin-resistant Klebsiella pneumoniae thriving in patients and in wastewater: what do they have in common?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Wastewater | 2022 |
Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis | 2022 |
Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Porins | 2022 |
Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Patients' Rooms; Retrospective Studies; Taiwan | 2022 |
Cefiderocol heteroresistance in Klebsiella pneumoniae is linked to mutations in the siderophore receptor cirA and β-lactamase activities.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Siderophores | 2022 |
Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
Topics: Bacteremia; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Cefiderocol Resistance in Klebsiella pneumoniae Is Linked to SHV Extended-Spectrum β-Lactamase Activities and Functional Loss of the Outer Membrane Porin OmpK35.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2023 |
Investigating Possible Interspecies Communication of Plasmids Associated with Transfer of Third-Generation Cephalosporin, Quinolone, and Colistin Resistance Between Simultaneously Isolated Escherichia Coli and Klebsiella Pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Coinfection; Colistin; Communication; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2023 |
Analysis of transmission-related third-generation cephalosporin-resistant Enterobacterales by electronic data mining and core genome multi-locus sequence typing.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2023 |
In vitro activity of cefiderocol in combination with new β-lactam/β-lactamase inhibitor combinations (βL-βLICs) against multidrug resistant KPC-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefiderocol; Cephalosporins; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests | 2023 |
Econometric ARIMA methodology to elucidate the evolution of trends in nosocomial antimicrobial resistance rates in the European Union.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Econometric; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
Genomic Insights into Two Colistin-Resistant
Topics: Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Genes, Bacterial; Genomics; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Virulence; Whole Genome Sequencing | 2020 |
Occurrence of Third-Generation Cephalosporins-Resistant
Topics: Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Fruit; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Vegetables | 2020 |
The Occurrence of bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Decreasing and stabilising trends of antimicrobial consumption and resistance in
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance | 2019 |
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tazobactam | 2020 |
Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
Topics: Adolescent; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Osteomyelitis; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores | 2020 |
Molecular epidemiology of nonsevere clinical mastitis caused by Klebsiella pneumoniae occurring in cows on 2 Wisconsin dairy farms.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Farms; Female; Klebsiella Infections; Klebsiella pneumoniae; Mastitis, Bovine; Milk; Molecular Epidemiology; Wisconsin | 2020 |
Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Transplantation; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
Topics: Cephalosporins; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Retrospective Studies; Tertiary Care Centers | 2020 |
Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; China; Comorbidity; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Family Characteristics; Female; Hospital Costs; Humans; Infant; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Retrospective Studies; Young Adult | 2020 |
Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunoassay; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2021 |
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2021 |
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Cefiderocol; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 2017 |
Complete DNA Sequence of an IncM1 Plasmid Bearing the Novel
Topics: Amazona; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; High-Throughput Nucleotide Sequencing; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Quinolones; Sequence Analysis, DNA | 2017 |
Klebsiella pneumoniae Isolates from Meningitis: Epidemiology, Virulence and Antibiotic Resistance.
Topics: Anti-Bacterial Agents; Bacterial Capsules; beta-Lactam Resistance; beta-Lactamases; Blood Bactericidal Activity; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Molecular Typing; Retrospective Studies; Serogroup; Taiwan; Virulence | 2017 |
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Mutation; Nitrobenzenes; Penicillins; Porins; Tetracyclines; Urinary Tract Infections | 2017 |
Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella; Klebsiella Infections; Lebanon; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2017 |
Risk factors and molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Xiamen, China.
Topics: Aged; beta-Lactamases; Case-Control Studies; Cephalosporins; China; Female; Genotyping Techniques; Healthcare-Associated Pneumonia; Hospitals; Humans; Intubation, Gastrointestinal; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Multilocus Sequence Typing; Multivariate Analysis; Odds Ratio; Risk Factors | 2017 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Prevalence; Tertiary Care Centers; Texas | 2018 |
Clinical efficacy and safety of cefepime-tazobactam in hospitalized patients in South India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult | 2018 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Dog Diseases; Dogs; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests | 2018 |
Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Medication Therapy Management; Microbial Sensitivity Tests; Slovenia | 2018 |
Detection of ISEcp1-associated bla
Topics: Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Colistin; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection.
Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity, Morbid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2018 |
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cephalosporins; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Host-Pathogen Interactions; Inflammation Mediators; Interleukin-1beta; Interleukin-8; Klebsiella Infections; Klebsiella pneumoniae; Lung; Male; Microspheres; Particle Size; Pneumonia, Bacterial; Polyesters; Rats, Wistar; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Necrosis Factor-alpha | 2018 |
Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Fluoroquinolones; Gene Expression; Genetic Variation; Genomics; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multigene Family; Penicillins; Phylogeny; Plasmids; Replicon | 2018 |
Emergence of the third-generation cephalosporin-resistant hypervirulent Klebsiella pneumoniae due to the acquisition of a self-transferable bla
Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Disease Models, Animal; Evolution, Molecular; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lepidoptera; Microbial Sensitivity Tests; Plasmids; Survival Analysis; Virulence | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Identification of
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genes, Bacterial; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests; Penicillins; Tetracyclines; Whole Genome Sequencing | 2019 |
Exposure to Sublethal Concentrations of Benzalkonium Chloride Induces Antimicrobial Resistance and Cellular Changes in
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzalkonium Compounds; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nitrobenzenes; Penicillins; Tetracyclines | 2019 |
Influence of antibiotic pressure on multi-drug resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2019 |
Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nephritis; Retrospective Studies; Spain | 2019 |
Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia.
Topics: Adolescent; Anti-Bacterial Agents; Cambodia; Carrier State; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gastrointestinal Tract; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Parasitic Diseases; Prevalence; Risk Factors; Surveys and Questionnaires; Whole Genome Sequencing | 2019 |
Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Delivery Systems; Inflammation; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Male; Microspheres; Pneumonia, Bacterial; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar | 2019 |
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Compassionate Use Trials; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Influenza, Human; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Treatment Outcome | 2019 |
Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Sequence Analysis, DNA | 2013 |
Hierarchical clustering as a rapid tool for surveillance of emerging antibiotic-resistance phenotypes in Klebsiella pneumoniae strains.
Topics: Algeria; Algorithms; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cluster Analysis; Computational Biology; Drug Resistance, Bacterial; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Prevalence; Software | 2013 |
Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Pool; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2013 |
Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011.
Topics: Adolescent; Adult; Aged; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Switzerland; Young Adult | 2013 |
Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sweden; Virulence | 2014 |
Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftaroline; Cephalosporins; Disease Models, Animal; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Meninges; Meningitis, Escherichia coli; Permeability; Rabbits; Treatment Outcome | 2013 |
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Half-Life; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Statistical; Penicillanic Acid; Plasmids; Tazobactam | 2013 |
Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Prevalence; Retrospective Studies; Risk Factors | 2014 |
Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cephalosporins; Drug Resistance, Bacterial; Feces; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Bacterial; Rats | 2014 |
Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals; Humans; Integrons; Iran; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2014 |
Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2014 |
Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genetic Variation; Genome, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Maryland; Middle Aged; Phosphoproteins; Plasmids; Sequence Analysis, DNA | 2014 |
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thigh | 2014 |
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Child; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2015 |
Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests; Organ Specificity; Substrate Specificity | 2014 |
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Investigational New Drug Application; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2015 |
Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections; Young Adult | 2015 |
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Iodides; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Protein Conformation | 2015 |
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carrier State; Cephalosporins; Europe; Feces; Genetic Variation; Genotype; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Molecular Typing; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA | 2015 |
Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Young Adult | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Asymptomatic Diseases; Bacteremia; Cephalosporins; Clavulanic Acid; Emergency Service, Hospital; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Patient Discharge; Retrospective Studies; Taiwan | 2015 |
Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Finland; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Prospective Studies | 2016 |
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Skin; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus; Tigecycline; United States | 2016 |
The Clinical Characteristics of Neonatal Sepsis Infection in Southwest China.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome | 2016 |
What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Inactivation, Metabolic; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Practice Guidelines as Topic | 2017 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prospective Studies; Young Adult | 2016 |
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2016 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
ESBL-Producing Strain of Hypervirulent Klebsiella pneumoniae K2, France.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Female; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing | 2016 |
Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.
Topics: Bacteremia; beta-Lactamases; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; HIV Infections; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors; South Africa | 2016 |
Nosocomial spread of Klebsiella pneumoniae isolates producing bla
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Plasmids | 2017 |
The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Population Surveillance; Taiwan; Urine; Young Adult | 2016 |
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Community-Acquired Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Propensity Score; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Infection in burn patients in a referral center in Colombia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Catheter-Related Infections; Central Venous Catheters; Cephalosporins; Child; Child, Preschool; Colombia; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Folliculitis; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection; Young Adult | 2017 |
Long-term outbreak of
Topics: beta-Lactamases; Cephalosporins; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Tertiary Care Centers | 2016 |
Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.
Topics: Adhesins, Escherichia coli; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Fimbriae Proteins; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests | 2017 |
Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Drainage; Endophthalmitis; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Meningitis, Bacterial; Middle Aged; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Treatment Outcome; Virulence Factors | 2008 |
Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Case Management; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Software | 2008 |
Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Quinolones; Risk Factors; Urinary Tract Infections; Urologic Surgical Procedures | 2008 |
Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Critical Care; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Medication Therapy Management; Microbial Sensitivity Tests; Middle Aged; Organizational Policy; Piperacillin | 2009 |
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Young Adult | 2008 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Epididymal abscess in renal transplant: uncommon presentation of Klebsiella septicemia.
Topics: Abscess; Adult; Cephalosporins; Cyclosporine; Epididymis; Genital Diseases, Male; Humans; Immunosuppressive Agents; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mycophenolic Acid; Prednisolone; Sepsis | 2010 |
Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pneumonia, Bacterial; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2010 |
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
The molecular characteristics of cefepime-susceptible Escherichia coli and Klebsiella spp. isolates with a positive β-lactamase screening test result but negative confirmation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; China; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Plasmids; Polymerase Chain Reaction | 2010 |
Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study.
Topics: Anti-Bacterial Agents; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit.
Topics: Adolescent; Bacterial Proteins; beta-Lactamases; Brazil; Carrier State; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Utilization; Female; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units; Klebsiella; Klebsiella Infections; Length of Stay; Male; Microbial Sensitivity Tests; Prospective Studies; Rectum; Risk Factors; Survival Analysis | 2010 |
Target lesions in the bladder from emphysematous cystitis.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cystitis; Cystoscopy; Emphysema; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder | 2010 |
Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Black or African American; Case-Control Studies; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Middle Aged; Multivariate Analysis; Nursing Homes; Odds Ratio; Renal Dialysis; Retrospective Studies; Risk Factors; United States | 2011 |
Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.
Topics: Animals; Bacterial Proteins; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genetic Complementation Test; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Phagocytosis; Porins; Sequence Analysis, DNA; Thienamycins; Virulence | 2011 |
Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Disease Outbreaks; Drug Utilization; Education; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2011 |
In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Penicillanic Acid; Tazobactam | 2011 |
Clinical and microbiological analysis of adult perianal abscess.
Topics: Abscess; Adult; Aged; Anal Canal; Anus Diseases; Cephalosporins; Diabetes Mellitus; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan | 2011 |
[Gastric wall abscess].
Topics: Abscess; Anti-Bacterial Agents; Cephalosporins; Gastroscopy; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Stomach Diseases; Tomography, X-Ray Computed | 2011 |
Increasing burden of hospital acquired infections: resistance to cephalosporin antibiotics among klebsiella and Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporins; Cost of Illness; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2011 |
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases.
Topics: Anti-Bacterial Agents; Area Under Curve; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Chromatography, Liquid; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Tandem Mass Spectrometry | 2012 |
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thigh | 2012 |
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome | 2012 |
Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Seasons; Urinary Tract Infections | 2012 |
Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258.
Topics: Africa; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Developing Countries; Genes, Bacterial; Genetic Variation; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Vietnam | 2013 |
Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Blotting, Western; Cefepime; Cephalosporins; Chloramphenicol; Computational Biology; DNA, Bacterial; Electrophoretic Mobility Shift Assay; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Operon; Osmotic Pressure; Oxidative Stress; Protein Kinases; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; RNA, Messenger; Sequence Homology, Amino Acid | 2012 |
OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Egypt; Female; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Sequence Data; Sequence Analysis, DNA | 2012 |
Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Young Adult | 2012 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Norway; Polymerase Chain Reaction | 2012 |
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping | 2012 |
Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.
Topics: beta-Lactamases; Cephalosporins; Data Collection; Disease Outbreaks; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Ontario | 2002 |
First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Cross Infection; Czech Republic; Drug Interactions; Drug Resistance, Multiple; Escherichia coli; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Proteus mirabilis; Slovakia | 2002 |
Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers.
Topics: Automation; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2003 |
Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.
Topics: Anti-Bacterial Agents; Argentina; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Utilization; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2004 |
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Penicillanic Acid; Penicillins; Piperacillin; Quinolines; Tazobactam | 2004 |
Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Phenotype | 2004 |
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Blotting, Southern; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Osteomyelitis; Staphylococcal Infections; Streptococcal Infections; United States | 2004 |
Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2004 |
Insufficient evidence that extended-spectrum cephalosporins effectively prevent metastatic infections related to Klebsiella pneumoniae-caused liver abscess.
Topics: Cefazolin; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Treatment Outcome | 2004 |
Detection of extended-spectrum beta-lactamases produced by Chilean isolates of Klebsiella pneumoniae by two synergy methods.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chile; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sensitivity and Specificity | 2004 |
Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.
Topics: Cephalosporins; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Feces; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Spain | 2004 |
[Fecal colonization by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Feces; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Spain | 2004 |
Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cephamycins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Taiwan | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome | 2005 |
Recurrent Klebsiella pneumoniae mycotic aneurysm in a diabetic patient and emergence of an extended-spectrum beta-lactamase (CTX-M-24)-containing Klebsiella pneumoniae strain after prolonged treatment with first-generation cephalosporins for mycotic aneur
Topics: Aneurysm; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Diabetes Complications; DNA, Bacterial; Drug Resistance, Microbial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2004 |
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Topics: Analysis of Variance; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Regression Analysis; Risk Factors | 2005 |
Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Prescriptions; Drug Resistance, Multiple; Hospitals, University; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hand; Hand Dermatoses; Health Personnel; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Onychomycosis | 2005 |
CTX-M: changing the face of ESBLs in the UK.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; United Kingdom | 2005 |
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome | 2005 |
Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Treatment Failure | 2005 |
Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2005 |
An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cohort Studies; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Feces; Female; Genes, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Molecular Epidemiology; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Thienamycins | 2005 |
[Cefprozil in the treatment of chronic maxillary sinusitis. Clinical and microbiological effectiveness and penetration into sinuses examination].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Chronic Disease; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome | 2005 |
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Cohort Studies; Costs and Cost Analysis; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2006 |
Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Taiwan | 2006 |
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome | 2006 |
Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum beta-lactamase-producing evaluation.
Topics: Base Sequence; beta-Lactamases; Cephalosporins; Clavulanic Acid; Genes, Bacterial; Guidelines as Topic; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Portugal; Random Allocation; Sensitivity and Specificity | 2006 |
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |
Pyogenic liver abscess: Klebsiella as an emerging pathogen.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Tomography, X-Ray Computed | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2006 |
[Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley | 2006 |
Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Treatment Outcome | 2007 |
Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Hospitals; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Polymorphism, Genetic; Random Amplified Polymorphic DNA Technique; Recombination, Genetic; Sequence Analysis, DNA | 2006 |
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2007 |
Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2006 |
Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Burn Units; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2006 |
Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2006 |
[High relationship between ciprofloxacin use and prevalence of ESBL Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Risk Factors | 2006 |
Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Transfer, Horizontal; Horse Diseases; Horses; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Sequence Data | 2007 |
Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, Urban; Humans; India; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2007 |
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2007 |
Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Czech Republic; Databases, Factual; Drug Utilization Review; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Comorbidity; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Retrospective Studies; Risk Factors; Taiwan | 2007 |
Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; China; Cohort Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Microbial Sensitivity Tests; Multivariate Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2007 |
Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
Topics: Acetyltransferases; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Birth Weight; Carrier State; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Gentamicins; Gestational Age; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Sequence Data; Plasmids; Risk Factors; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens; Surgical Procedures, Operative | 2007 |
[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Risk Factors; Urinary Tract Infections | 2007 |
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymerase Chain Reaction | 2008 |
Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2008 |
Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Computers; Drug Utilization; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Medication Therapy Management; Microbial Sensitivity Tests; Organizational Policy; Pseudomonas aeruginosa | 2008 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
[Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia].
Topics: Cephalosporins; Cephamycins; Cerebral Ventricles; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Sepsis | 1983 |
Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
Topics: Animals; Cefazolin; Cefotaxime; Ceftazidime; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Rats | 1982 |
Ceftazidime: a new approach in the treatment of moderate and severe infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors | 1984 |
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
Topics: Aged; Blood-Brain Barrier; Cephalosporins; Cephamycins; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Male; Meningitis; Middle Aged; Moxalactam | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Cefoperazone in Klebsiella meningitis: a case report.
Topics: Cefoperazone; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy.
Topics: Abdomen; Abdominal Injuries; Abscess; Adult; Anti-Bacterial Agents; Cephalosporinase; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Genetic Variation; Humans; Klebsiella; Klebsiella Infections; Male | 1983 |
Ceftazidime in the treatment of urinary tract infection.
Topics: Aged; Ceftazidime; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas Infections; Streptococcal Infections; Urinary Catheterization; Urinary Tract Infections | 1982 |
The significance of bacterial kinetic examinations for an adequate dosage of antibiotic.
Topics: Anti-Bacterial Agents; Cephalosporins; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Kinetics; Klebsiella Infections; Klebsiella pneumoniae | 1980 |
[Sefril in the treatment of toxic diarrhea in infants].
Topics: Cephalosporins; Cephradine; Diarrhea, Infantile; Enterobacteriaceae Infections; Enterotoxins; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Proteus Infections; Proteus mirabilis; Proteus vulgaris | 1980 |
Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Cefazolin; Cefotiam; Cephalosporins; Disease Models, Animal; Drug Administration Schedule; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia | 1980 |
Nosocomial pneumonia.
Topics: Aminoglycosides; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin G; Pneumococcal Infections; Pneumonia; Pseudomonas Infections; Staphylococcal Infections | 1981 |
Acute klebsiella epiglottitis: considerations for initial antibiotic coverage.
Topics: Adult; Ampicillin; Cephalosporins; Epiglottis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Laryngitis; Male; Penicillin Resistance | 1982 |
Klebsiella bacteremia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; California; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Male; Middle Aged; Prognosis; Sepsis; Space-Time Clustering | 1980 |
Granulocytopenia and septicaemia.
Topics: Agranulocytosis; Cephalosporins; Cephalothin; Humans; Klebsiella Infections; Sepsis | 1980 |
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
Topics: Bacterial Infections; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Culture Media; Enterobacter; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus | 1995 |
Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
Topics: beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovakia | 1995 |
Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
Topics: Bacteremia; beta-Lactam Resistance; Cefuroxime; Cephalosporins; Drug Utilization; Escherichia coli; Escherichia coli Infections; Finland; Humans; Klebsiella; Klebsiella Infections | 1994 |
Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Canada; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 1993 |
Klebsiella pneumoniae meningitis: prognostic factors.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Female; Humans; Incidence; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Middle Aged; Prognosis; Taiwan | 1994 |
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; DNA Probes; DNA, Bacterial; Humans; Isoelectric Focusing; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Phenotype; Plasmids | 1993 |
Severe Klebsiella infection as a cause of mortality in neonates in Harare, Zimbabwe: evidence from postmortem blood cultures.
Topics: Bacteremia; Cause of Death; Cephalosporins; Drug Resistance, Microbial; Female; Gentamicins; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infant, Premature, Diseases; Klebsiella; Klebsiella Infections; Male; Penicillin Resistance; Penicillins; Zimbabwe | 1993 |
Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Muscular Diseases; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1993 |
Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Topics: Abdominal Abscess; Amino Acid Sequence; Ampicillin; Animals; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Molecular Biology; Molecular Sequence Data; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; R Factors; Rats; Sulbactam | 1996 |
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.
Topics: Aztreonam; Bacteriophage Typing; beta-Lactamases; Ceftazidime; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Monobactams; Plasmids | 1995 |
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Escherichia coli Infections; Fluorouracil; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Survival Analysis | 1996 |
Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.
Topics: Bacterial Typing Techniques; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Fatal Outcome; Genes, Bacterial; Humans; Infant; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Plasmids | 1995 |
Treatment failure due to extended spectrum beta-lactamase.
Topics: Adolescent; beta-Lactamases; Cefotaxime; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Failure | 1996 |
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.
Topics: Adolescent; Adult; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Plasmids | 1996 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.
Topics: Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Veterans; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Ohio; Plasmids | 1996 |
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteriophages; Base Sequence; beta-Lactamases; Blotting, Southern; Cefoperazone; Cephalosporins; Cloning, Molecular; Culture Media; Databases, Factual; Drug Therapy, Combination; Indicators and Reagents; Klebsiella; Klebsiella Infections; Molecular Sequence Data; Molecular Weight; Nucleic Acid Hybridization; Plasmids; Sulbactam | 1996 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Retrospective Studies; Time Factors | 1995 |
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Cephalosporins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutation; Nalidixic Acid; Polymerase Chain Reaction | 1997 |
Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cephalosporins; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Hospitals; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nursing Homes | 1997 |
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
Topics: Abdominal Abscess; Animals; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1997 |
Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases in a university hospital.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Deoxyribonucleases, Type II Site-Specific; Disease Outbreaks; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Polymorphism, Restriction Fragment Length | 1998 |
Klebsiella pneumoniae meningitis: analysis on clinical features of thirty-two adult patients.
Topics: Adult; Aged; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Middle Aged; Prognosis | 1997 |
Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Contamination; Drug Resistance, Microbial; Equipment Contamination; Female; Gels; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Ultrasonography | 1998 |
Intraperitoneal abscess in a new born secondary to Klebsiella septicaemia--a case report.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Peritoneal Cavity | 1998 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Missouri; Molecular Sequence Data | 1998 |
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; False Negative Reactions; False Positive Reactions; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple; Escherichia coli; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Proteus mirabilis | 1998 |
[Necrotizing enterocolitis in the postop period of cardiac surgery in the neonatal period].
Topics: Cephalosporins; Enterocolitis, Necrotizing; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Klebsiella Infections; Male; Postoperative Period | 1998 |
Obstructive jaundice due to multiple hepatic abscesses.
Topics: Bacteroides Infections; Cefozopran; Cephalosporins; Cholestasis; Drainage; Escherichia coli Infections; Humans; Infusions, Intravenous; Klebsiella Infections; Liver Abscess; Male; Middle Aged | 1998 |
Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.
Topics: beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Child; Cross Infection; DNA Fingerprinting; Genes, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1998 |
Pericecal appendiceal abscess with drainage during colonoscopy.
Topics: Abdominal Abscess; Appendectomy; Appendicitis; Biopsy; Cecum; Cefazolin; Cephalosporins; Colonoscopy; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Laparotomy; Male; Middle Aged; Rupture, Spontaneous; Suction; Tomography, X-Ray Computed | 1999 |
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
Topics: Animals; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Spleen; Thienamycins | 1998 |
Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Conjugation, Genetic; Croatia; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 1998 |
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Homes for the Aged; Humans; Klebsiella; Klebsiella Infections; Male; Multivariate Analysis; Nursing Homes; Plasmids | 1999 |
Short-course ceftriaxone therapy in spontaneous bacterial peritonitis.
Topics: Adolescent; Adult; Ceftriaxone; Cephalosporins; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Liver Diseases; Male; Middle Aged; Peritonitis; Prospective Studies | 1998 |
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.
Topics: Bacterial Proteins; beta-Lactamases; Cefoxitin; Ceftazidime; Cephalosporins; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction | 1999 |
Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate.
Topics: Automation; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; False Negative Reactions; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results | 1999 |
Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cefotaxime; Cephalosporins; Inflammation; Injections, Subcutaneous; Interleukins; Klebsiella Infections; Klebsiella pneumoniae; Lung; Macrophages, Alveolar; Mice; Neutrophils; Tumor Necrosis Factor-alpha | 1999 |
[Liver abscess caused by Klebsiella pneumoniae in diabetic patients].
Topics: Aged; Cefotaxime; Cephalosporins; Diabetes Complications; Follow-Up Studies; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed | 1999 |
[Monitoring antibiotic resistance in Argentina. The WHONET program, 1995-1996].
Topics: Cephalosporins; Drug Resistance, Microbial; Enterococcus; Escherichia coli Infections; Europe; Female; Gentamicins; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Latin America; Male; Oxacillin; Population Surveillance; Staphylococcus aureus; Streptococcal Infections; United States; Urinary Tract Infections; World Health Organization | 1999 |
Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Treatment Outcome | 2000 |
Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Isoelectric Focusing; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Portugal; Sequence Analysis, DNA | 2000 |
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Hafnia; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Plasmids; Polymerase Chain Reaction | 2000 |
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2000 |
Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime.
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Culture Media; Denmark; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2000 |
[Infectious lesions of recurrent laryngeal and hypoglossal nerves as a rare complication of phlegmon of deep neck spaces].
Topics: Aged; Anti-Bacterial Agents; Cefazolin; Cellulitis; Cephalosporins; Cranial Nerve Diseases; Drainage; Female; Gentamicins; Humans; Hypoglossal Nerve; Klebsiella Infections; Neck; Penicillins; Recurrent Laryngeal Nerve; Time Factors | 2000 |
Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.
Topics: Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2000 |
Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefpodoxime; Ceftizoxime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Sensitivity and Specificity | 2000 |
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis | 2001 |
Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae | 2000 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |
Epidemiology of ceftazidime-resistant Klebsiella pneumoniae in a large university hospital in Tel Aviv.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Hospitals, University; Hospitals, Urban; Humans; Incidence; Intensive Care Units; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Probability; Risk Factors | 2000 |
Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
Topics: Cefazolin; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2001 |
[Studies on the biological and clinical characteristics of acquired pneumonia caused by K. planticola].
Topics: Adult; Aged; Aged, 80 and over; Cephalosporins; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Pneumonia, Bacterial | 1998 |
Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia.
Topics: Base Sequence; beta-Lactamases; Cephalosporins; Croatia; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction | 2001 |
Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Isoelectric Point; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Treatment Outcome | 2002 |
Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Chicago; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Urban Population | 2002 |
Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Culture Media; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids | 2002 |
Susceptibility of Klebsiella species to quinolones and cephalosporins.
Topics: Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella; Klebsiella Infections; Quinolones; Zimbabwe | 2001 |
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam | 2002 |
Klebsiella pneumoniae brain abscess in a Taiwanese adult.
Topics: Acyclovir; Brain Abscess; Cefepime; Cephalosporins; Ethnicity; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Taiwan; Vancomycin | 2002 |
[Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
Topics: Animals; Cephalexin; Cephalosporins; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Infections; Klebsiella; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Protein Binding; Proteus Infections; Salmonella; Shigella; Species Specificity; Staphylococcal Infections; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 1976 |
Klebsiella cross-infection with capsular serotypes 68 and 21.
Topics: Aged; Cefoxitin; Cephalosporins; Cross Infection; Drug Evaluation; Drug Resistance, Microbial; England; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; London; Male; Urinary Tract Infections | 1979 |
Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cephalosporins; Drug Therapy, Combination; Endometritis; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Proteus Infections; Proteus vulgaris; Pyelonephritis; Sepsis; Tobramycin | 1978 |
Clinical experience with cefadroxil in upper and lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Bronchiectasis; Bronchitis; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Otitis Media; Pneumococcal Infections; Pneumonia; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Streptococcal Infections; Tonsillitis | 1978 |
[Progress in antibacterial chemotherapy].
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Humans; Klebsiella Infections; Penicillins; Ticarcillin | 1978 |
[Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Klebsiella Infections; Male; Proteus Infections; Staphylococcal Infections | 1979 |
[New antibiotics].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Gram-Negative Aerobic Bacteria; Humans; Klebsiella Infections; Penicillin Resistance; Penicillins; Pseudomonas Infections; Sepsis | 1979 |
A clinical approach to the choice of antimicrobial usage, case number eight: Klebsiella pneumoniae pneumonia.
Topics: Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia | 1979 |
Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
Topics: Animals; Cephalosporins; Dogs; Enterobacteriaceae; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pyelonephritis; Rats; Staphylococcal Infections; Streptococcal Infections | 1977 |
Antibiotics in pyelonephritis.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Proteus Infections; Pseudomonas Infections; Pyelonephritis | 1979 |
Cephazolin: a comparison to ampicillin in respiratory and urinary infections with dosage regulation by a nomogram.
Topics: Ampicillin; Cefazolin; Cephalosporins; Dose-Response Relationship, Drug; Drug Hypersensitivity; Escherichia coli Infections; Haemophilus Infections; Half-Life; Humans; Kidney Failure, Chronic; Klebsiella Infections; Pneumococcal Infections; Proteus Infections; Respiratory Tract Infections; Staphylococcal Infections; Urinary Tract Infections | 1976 |
[Therapy of bacterial penumonias and their complications with and without pathogen isolation].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Hypersensitivity; Empyema; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Lung Diseases, Fungal; Penicillin Resistance; Penicillins; Pleural Diseases; Pneumococcal Infections; Pneumonia; Pneumonia, Staphylococcal; Streptococcal Infections | 1975 |
3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
Topics: Animals; Cephalosporins; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Methods; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes; Thiophenes | 1975 |
Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.
Topics: Cefazolin; Cephalosporins; Creatinine; Escherichia coli Infections; Glomerular Filtration Rate; Humans; Klebsiella Infections; Monitoring, Physiologic | 1975 |
[The bacterial infections in patients with acute leukemia and their treatment by antibiotics, with special reference to Klebsiella and Pseudomonas infections (author's transl)].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Humans; Klebsiella Infections; Leukemia; Male; Penicillins; Pseudomonas Infections | 1975 |
[Combination effect of KW-2228 and cephem antibiotics in a systemic infection model in neutropenic mice].
Topics: Animals; Cephalosporins; Cyclophosphamide; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Neutropenia; Recombinant Proteins | 1992 |
In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
Topics: Animals; Bacteria; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Streptococcal Infections; Streptococcus pneumoniae | 1992 |
[Identification of a new penicillinase in a Klebsiella pneumoniae strain of which a mutant also produces an esterase hydrolyzing cephalothin and cefotaxime].
Topics: Acetylesterase; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Penicillin Resistance; Penicillinase; Penicillins | 1992 |
Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
Topics: Animals; Blood Proteins; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Microbial Sensitivity Tests; Protein Binding; Staphylococcal Infections; Staphylococcus aureus | 1992 |
[Diagnosis and therapy of pneumonia caused by gram-negative bacillus including legionella].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Haemophilus Infections; Humans; Klebsiella Infections; Legionnaires' Disease; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cephalosporinase; Cephalosporins; Cloning, Molecular; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Microbial; Enzyme Induction; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 1990 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
[Pathogenic and clinical changes of pneumonia in the recent 10 years].
Topics: Adult; Cephalosporins; Drug Resistance, Microbial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 1990 |
Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.
Topics: Agranulocytosis; Animals; Cefamandole; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mice; Protein Binding; Specific Pathogen-Free Organisms | 1990 |
New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivatives leading to MT0703.
Topics: Animals; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Klebsiella Infections; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Spectrophotometry; Structure-Activity Relationship | 1990 |
Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.
Topics: Animals; Cefazolin; Cefmenoxime; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Models, Biological; Pneumonia | 1990 |
Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
Topics: Animals; Cefpirome; Cephalosporins; Escherichia coli; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Methicillin; Mice; Penicillin Resistance; Pseudomonas Infections; Pyelonephritis; Rats; Staphylococcal Infections; Staphylococcus aureus; Uterine Diseases | 1990 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacteriaceae Infections; Escherichia coli Infections; Hexosyltransferases; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Proteus Infections; Staphylococcal Infections; Streptococcal Infections | 1987 |
Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice.
Topics: Animals; Cefpirome; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Lung; Male; Mice; Mice, Inbred Strains; Pneumonia | 1986 |
Comparative laboratory studies on alpha-methoxyimino furyl- and phenylacetamido cephalosporins: structure-activity relationships.
Topics: Animals; Bacteria; Cefazolin; Cefuroxime; Cephalosporins; Escherichia coli Infections; Half-Life; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Saimiri; Structure-Activity Relationship | 1986 |
[HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Citrobacter; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Klebsiella Infections; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella Infections, Animal; Salmonella typhimurium; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1985 |
Antimicrobial drugs for treatment of infections caused by aerobic gram-negative bacilli.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cephalosporins; Chloramphenicol; Dysentery, Bacillary; Escherichia coli Infections; Gentamicins; Haemophilus Infections; Humans; Kanamycin; Klebsiella Infections; Polymyxins; Proteus Infections; Pseudomonas Infections; Salmonella Infections; Sulfonamides; Tetracycline | 1974 |
Penicillins and cephalosporins from isothiazolylacetic acids.
Topics: Acetates; Amides; Ampicillin; Animals; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Escherichia coli; Klebsiella; Klebsiella Infections; Methods; Mice; Penicillin G; Penicillins; Salmonella; Salmonella typhi; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Thiazoles | 1968 |
Studies of absorption, excretion, antibacterial and clinical effect of cephalexin.
Topics: Administration, Oral; Adolescent; Adult; Agar; Aged; Candidiasis; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Nausea; Proteus; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Urinary Tract Infections; Vulvovaginitis | 1970 |
Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-mandelamido-3-cephem-4-carboxylic acids.
Topics: Amides; Animals; Bacteria; Cephalosporins; Dogs; Escherichia coli Infections; Klebsiella Infections; Magnetic Resonance Spectroscopy; Mandelic Acids; Mice; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship | 1974 |
[Urosepsis in urinary calculi].
Topics: Adult; Ampicillin; Carbenicillin; Cephalosporins; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Male; Nephrectomy; Proteus Infections; Pseudomonas Infections; Sepsis; Urinary Calculi | 1974 |
Unusual renal infections.
Topics: Abscess; Adult; Aged; Cephalosporins; Cephalothin; Drainage; Female; Gentamicins; Humans; Kidney Diseases; Klebsiella Infections; Male; Middle Aged; Nephrectomy; Proteus Infections; Streptococcal Infections; Sulfides; Tetrazoles; Thiadiazoles; Tomography, X-Ray; Urography | 1973 |
Synthesis of 6-aminopenicillanic acid derivatives. IV. 6-(syndone-3-acetamido) penicillanates and 7-(sydone-3-acetamido) cephalosporanates.
Topics: Acetates; Ampicillin; Animals; Cephalosporins; Cephalothin; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Injections, Subcutaneous; Klebsiella; Klebsiella Infections; Mice; Oxadiazoles; Penicillins; Salmonella typhi; Staphylococcal Infections; Staphylococcus | 1968 |
[Cephalosporins as new antibiotics].
Topics: Cephalosporins; Enteritis; Escherichia coli Infections; Gonorrhea; Humans; Influenza, Human; Klebsiella Infections; Pneumococcal Infections; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Whooping Cough | 1968 |
Use of the cephalosporins in the identification of Klebsiella.
Topics: Bacteriological Techniques; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Humans; Klebsiella; Klebsiella Infections; Methods; Respiratory Tract Infections; Serratia; Urinary Tract Infections | 1969 |
Clinical experience with cephalexin in New Zealand.
Topics: Aged; Cephalosporins; Escherichia coli Infections; Humans; Klebsiella Infections; Male; New Zealand; Respiratory Tract Infections; Urinary Tract Infections | 1970 |
Clinical evaluation of cephalexin in urinary tract infection.
Topics: Cephalosporins; Escherichia coli Infections; Humans; Klebsiella Infections; Proteus Infections; Staphylococcal Infections; Urinary Tract Infections | 1970 |
Cephalexin in chronic and recurrent urinary infections: laboratory and clinical studies.
Topics: Aged; Cephalosporins; Chronic Disease; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Proteus Infections; Urinary Tract Infections | 1970 |
A urological evaluation of cephalexin.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Chemical Phenomena; Chemistry; Chronic Disease; Escherichia coli Infections; Evaluation Studies as Topic; Female; Humans; Hydrogen-Ion Concentration; Klebsiella Infections; Male; Middle Aged; Solubility; Urinary Tract Infections | 1971 |
Klebsiella infections.
Topics: Cephalosporins; Humans; Klebsiella Infections; Respiratory Tract Infections | 1969 |
Panel discussion of the treatment of serious Gram-negative infections.
Topics: Cephalosporins; Chronic Disease; Female; Humans; Klebsiella Infections; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Sepsis | 1971 |
Treatment of pneumonia in childhood with cephalexin.
Topics: Adolescent; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Pneumococcal Infections; Pneumonia; Streptococcal Infections | 1971 |